Frequently Asked Questions
The market is segmented based on , By Disorder (Meningocele, occulta, myelomeningocele, and Closed Neural Tube Defects), Type (Spina Bifida Cystica, Spina Bifida Occulta), Treatment (Medicines, Medical Procedures, Surgeries, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
.
The Global Spina Bifida Treatment Market size was valued at USD 2.42 USD Billion in 2021.
The Global Spina Bifida Treatment Market is projected to grow at a CAGR of 8.4% during the forecast period of 2022 to 2029.
The major players operating in the market include Pfizer , Regeneron Pharmaceuticals , Astellas Pharma , Merck KGaA, Sanofi, BioRad Laboratories , Biocare Medical LLC, Lilly, Teva Pharmaceutical Industries, B. Braun SE, Cardinal Health, BD, Boston Scientific Corporation, Hologic .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
